UA5954A1 - Спосіб отримання (+)-4-ді-(н-пропіл)-аміно-6-карбамоіл-1,3,4,5-тетрагідробенз (с,д) індола або його фармацевтично придатної солі - Google Patents

Спосіб отримання (+)-4-ді-(н-пропіл)-аміно-6-карбамоіл-1,3,4,5-тетрагідробенз (с,д) індола або його фармацевтично придатної солі

Info

Publication number
UA5954A1
UA5954A1 UA3856855A UA3856855A UA5954A1 UA 5954 A1 UA5954 A1 UA 5954A1 UA 3856855 A UA3856855 A UA 3856855A UA 3856855 A UA3856855 A UA 3856855A UA 5954 A1 UA5954 A1 UA 5954A1
Authority
UA
Ukraine
Prior art keywords
teterahydrobenzo
indol
propyl
amino
carbamoyl
Prior art date
Application number
UA3856855A
Other languages
English (en)
Russian (ru)
Inventor
Едвард Флауф Майкл
Эдвард Флауф Майкл
Original Assignee
Елі Ліллі Енд Компані
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Елі Ліллі Енд Компані, Эли Лилли Энд Компани filed Critical Елі Ліллі Енд Компані
Publication of UA5954A1 publication Critical patent/UA5954A1/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Спосіб отримання (±)-4-ди-(н-пропіл)-аміно-6-карбамоїл-1,3,4,5-тетрагідробенз (с,d) індолу формули І або його фармацевтично прийнятної солі. (±)-4-ди-(н-пропіл)-аміно-6-ціано-1,3,4,5-тетрагідробенз (с,d) індол піддають гідролізу гідрооксидом калію в середовищі трет-бутанолу в атмосфері азоту в присутності диметилсульфоксиду з виділенням цільового продукту хроматографічним розділенням и в разі необхідності продукт переводять у фармацевтично прийнятну сіль кислоти.
UA3856855A 1984-02-06 1985-02-04 Спосіб отримання (+)-4-ді-(н-пропіл)-аміно-6-карбамоіл-1,3,4,5-тетрагідробенз (с,д) індола або його фармацевтично придатної солі UA5954A1 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57709684A 1984-02-06 1984-02-06

Publications (1)

Publication Number Publication Date
UA5954A1 true UA5954A1 (uk) 1994-12-29

Family

ID=24307259

Family Applications (1)

Application Number Title Priority Date Filing Date
UA3856855A UA5954A1 (uk) 1984-02-06 1985-02-04 Спосіб отримання (+)-4-ді-(н-пропіл)-аміно-6-карбамоіл-1,3,4,5-тетрагідробенз (с,д) індола або його фармацевтично придатної солі

Country Status (24)

Country Link
EP (1) EP0153083B1 (uk)
JP (2) JPH0699388B2 (uk)
KR (1) KR860001892B1 (uk)
AR (1) AR240641A1 (uk)
AT (1) ATE53021T1 (uk)
AU (1) AU572258B2 (uk)
CA (1) CA1291484C (uk)
CY (1) CY1657A (uk)
DE (1) DE3577848D1 (uk)
DK (1) DK167572B1 (uk)
ES (2) ES8605236A1 (uk)
GR (1) GR850313B (uk)
HK (1) HK63792A (uk)
HU (1) HU193941B (uk)
IE (1) IE57916B1 (uk)
IL (1) IL74222A (uk)
MY (1) MY102763A (uk)
NZ (1) NZ211031A (uk)
PH (1) PH20490A (uk)
PT (1) PT79925B (uk)
SG (1) SG66992G (uk)
SU (1) SU1375128A3 (uk)
UA (1) UA5954A1 (uk)
ZA (1) ZA85916B (uk)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5273975A (en) * 1989-06-09 1993-12-28 The Upjohn Company Heterocyclic amines having central nervous system activity
IL97309A (en) * 1990-02-26 1996-11-14 Lilly Co Eli Intermediates for hexahydrobenz] [DC indoles and a process for making their pure enantiomers
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli Xahydrobenz [DC] Induced indoles in position 6, their preparation process and pharmaceutical preparations containing them
US5039820A (en) * 1990-02-26 1991-08-13 Eli Lilly And Company 4-amino-6-iodo-hexahydrobenz(cd)indoles
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5340838A (en) * 1990-05-04 1994-08-23 Eli Lilly And Company Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
US5229410A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
US5656653A (en) * 1991-03-28 1997-08-12 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
KR100335548B1 (ko) 1993-07-27 2002-10-04 파마시아 앤드 업존 캄파니 중추신경계활성을갖는헤테로사이클아민
US5385928A (en) * 1994-05-18 1995-01-31 Eli Lilly And Company Tetrahydrobenz [CD] indazoles, compositions and use
FR2732964B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux amides tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US7074927B2 (en) 1999-05-13 2006-07-11 Pharmacia & Upjohn Company Heterocyclic amines having central nervous system activity
TW200732302A (en) * 2005-12-13 2007-09-01 Daicel Chem Indoline derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194811A (en) * 1963-09-05 1965-07-13 Merck & Co Inc Aroyl-benzindolyl acids
US4282240A (en) * 1979-11-23 1981-08-04 Merck & Co., Inc. Amino substituted tetrahydrobenzindoles
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines

Also Published As

Publication number Publication date
HUT37121A (en) 1985-11-28
MY102763A (en) 1992-10-31
DK48785D0 (da) 1985-02-04
JPH0699388B2 (ja) 1994-12-07
JPH06279406A (ja) 1994-10-04
CY1657A (en) 1993-05-14
JPS60208959A (ja) 1985-10-21
AR240641A1 (es) 1990-07-31
AU3841985A (en) 1985-08-15
IE850263L (en) 1985-08-06
EP0153083B1 (en) 1990-05-23
KR860001892B1 (ko) 1986-10-24
ZA85916B (en) 1986-09-24
HU193941B (en) 1987-12-28
ES548942A0 (es) 1987-04-16
IE57916B1 (en) 1993-05-19
ES540151A0 (es) 1986-03-16
HK63792A (en) 1992-08-28
PT79925B (en) 1987-02-05
ATE53021T1 (de) 1990-06-15
DK167572B1 (da) 1993-11-22
DE3577848D1 (de) 1990-06-28
NZ211031A (en) 1989-08-29
GR850313B (uk) 1985-06-05
ES8704894A1 (es) 1987-04-16
AU572258B2 (en) 1988-05-05
ES8605236A1 (es) 1986-03-16
JPH0745470B2 (ja) 1995-05-17
PH20490A (en) 1987-01-21
IL74222A (en) 1988-07-31
EP0153083A2 (en) 1985-08-28
EP0153083A3 (en) 1987-01-14
CA1291484C (en) 1991-10-29
DK48785A (da) 1985-09-03
SU1375128A3 (ru) 1988-02-15
KR850005825A (ko) 1985-09-26
SG66992G (en) 1992-09-04
IL74222A0 (en) 1985-05-31
PT79925A (en) 1985-03-01

Similar Documents

Publication Publication Date Title
UA5954A1 (uk) Спосіб отримання (+)-4-ді-(н-пропіл)-аміно-6-карбамоіл-1,3,4,5-тетрагідробенз (с,д) індола або його фармацевтично придатної солі
CA1259074C (uk)
TW197439B (uk)
AU595270B2 (en) Process for the preparation of (2,2)-paracyclophane and derivatives thereof
EP0242896A3 (en) Novel intermediates useful in the production of gem-diaminoalkane derived sweeteners
UA7088A1 (uk) Спосіб одержання солі 2-(2-гідроксіетоксі)етіламіна та 3,6-діхлор-2-метоксібензойної кислоти
AU4513885A (en) Production of 2'-deoxyadenosines
ES8301961A1 (es) Procedimiento para la preparacion de nuevos benzo (b) tiofe-nos
HUT47114A (en) Process for producing podophyllotoxin and podophyllotoxin derivatives
EP0380363A3 (en) Process for producing tetrabromobisphenol a
AU6393686A (en) Process for preparing halogen magnesium alanate and use thereof
ES8700652A1 (es) Un metodo de preparar n-4-(3-aminopropil)-aminobutil-2,2-di-hidroxietanoamida
ES2026059A6 (es) Procedimiento mejorado para la sintesis de 1-((1-(2-(trifluoreometil)-4-pirimidinil)-4-piperidinil)metil)-2-pirrolidinona.
EP0002834A3 (en) Preparation of salicylic acid and derivatives
HUT36123A (en) Process for the production of 5h-/1/ benzopyrano /2,3-d/-pyrimidine-derivatives
CA2012081A1 (en) 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi 2 derivatives
AU577835B2 (en) Sodium perborate monohydrate from tetrahydrate
ES8400401A1 (es) "un procedimiento para preparar un 1,4-dialcohilo inferior-3-alcoxicarbonilo inferior-pirrol-2-acetato de alcohilo inferior".
ES2001662A6 (es) Metodo para producir acidos 6b -halopenicilanicos asi como sales dse los mismos.
TW362019B (en) Stable preparation of sodium 1,4-dimethylisopropylazulene-3-sulfonate and process thereof
EP0082656A3 (en) Preparation of cepham derivatives
SU960185A1 (ru) Способ получени 1-трифенилфосфоранилиден-4-ароил-5-карбэтоксициклопент-4-ен-2,3-дионов
SU1152953A1 (ru) Способ получени 3-(2-пиридилдитио)пропионовой кислоты
HUT58999A (en) Process for producing aerosol preparations containijng sodium-chrome-glycate
SU1045566A1 (ru) Хлорангидрид 3,4-дициано - 4′- -карбоксидифенилоксида в качестве полупродукта для синтеза тетранитрилов ароматических тетракарбоновых кислот, тетранитрилы ароматических тетракарбоновых кислот как мономеры для синтеза полигексазоцикланов и полигексазоцикланы как материалы для электропроводящих покрытий